GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (NYSE:ABT) » Definitions » Accumulated other comprehensive income (loss)

ABT (Abbott Laboratories) Accumulated other comprehensive income (loss) : $-7,804 Mil (As of Sep. 2024)


View and export this data going back to 1949. Start your Free Trial

What is Abbott Laboratories Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Abbott Laboratories's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2024 was $-7,804 Mil.

Abbott Laboratories's quarterly Accumulated other comprehensive income (loss) increased from Mar. 2024 ($-8,166 Mil) to Jun. 2024 ($-8,135 Mil) and increased from Jun. 2024 ($-8,135 Mil) to Sep. 2024 ($-7,804 Mil).

Abbott Laboratories's annual Accumulated other comprehensive income (loss) increased from Dec. 2021 ($-8,374 Mil) to Dec. 2022 ($-8,051 Mil) and increased from Dec. 2022 ($-8,051 Mil) to Dec. 2023 ($-7,839 Mil).

Abbott Laboratories Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Abbott Laboratories's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Accumulated other comprehensive income (loss) Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8,465.00 -8,946.00 -8,374.00 -8,051.00 -7,839.00

Abbott Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8,480.00 -7,839.00 -8,166.00 -8,135.00 -7,804.00

Abbott Laboratories Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Abbott Laboratories Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (NYSE:ABT) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
SYK BSX MDT EW DXCM STE ZBH PODD GMED BIO XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 LSE:SN. ASX:COH BRKR OCSE:DEMANT PEN
Traded in Other Exchanges
ABT:Peru ABT:Mexico ABLd:UK ABL:Germany ABL:Germany ABL:Germany ABL:Germany ABT:Switzerland ABTT34:Brazil ABT:Austria ABT:Argentina
Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Website
https://www.abbottinvestor.com
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Executives
Robert B Ford officer: Senior Vice President 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092
Mccoy John A. Jr. officer: VICE PRESIDENT C/O ABBOTT LABORATORIES, 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Robert E Funck officer: Vice President, Controller 100 ABBOTT PARK ROAD, D-378, AP6D-2, ABBOTT PARK IL 60064-6092
Lisa D Earnhardt officer: Executive Vice President 1555 ADAMS DRIVE, C/O INTERSECT ENT, INC., MENLO PARK CA 94025
Salvadori Daniel Gesua Sive officer: Senior Vice President 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064-6092
Mary K Moreland officer: Executive Vice President 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Hubert L Allen officer: Executive Vice President 100 ABBOTT PARK ROAD, AP6C-1N, ABBOTT PARK IL 60064-6092
Louis H. Morrone officer: EXECUTIVE VICE PRESIDENT 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Andrea F Wainer officer: Executive Vice President 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Daniel J Starks director ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117
Michael F Roman director 3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST. PAUL MN 55144-1000
Patricia Paola Gonzalez director 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Philip P Boudreau officer: Vice President 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Michael O'grady director 50 S LASALLE STREET, CHICAGO IL 60603
Gregory A Ahlberg officer: Senior Vice President 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064